Organogenesis Holdings Stock Forward View
| ORGO Stock | USD 4.00 0.01 0.25% |
Organogenesis Stock outlook is based on your current time horizon.
As of today, the value of RSI of Organogenesis Holdings' share price is approaching 46. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Organogenesis Holdings, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Using Organogenesis Holdings hype-based prediction, you can estimate the value of Organogenesis Holdings from the perspective of Organogenesis Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Organogenesis Holdings on the next trading day is expected to be 5.22 with a mean absolute deviation of 0.30 and the sum of the absolute errors of 18.37. Organogenesis Holdings after-hype prediction price | USD 4.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Organogenesis | Build AI portfolio with Organogenesis Stock |
Organogenesis Holdings Additional Predictive Modules
Most predictive techniques to examine Organogenesis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Organogenesis using various technical indicators. When you analyze Organogenesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Organogenesis Holdings Naive Prediction Price Forecast For the 3rd of February
Given 90 days horizon, the Naive Prediction forecasted value of Organogenesis Holdings on the next trading day is expected to be 5.22 with a mean absolute deviation of 0.30, mean absolute percentage error of 0.15, and the sum of the absolute errors of 18.37.Please note that although there have been many attempts to predict Organogenesis Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Organogenesis Holdings' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Organogenesis Holdings Stock Forecast Pattern
| Backtest Organogenesis Holdings | Organogenesis Holdings Price Prediction | Research Analysis |
Organogenesis Holdings Forecasted Value
In the context of forecasting Organogenesis Holdings' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Organogenesis Holdings' downside and upside margins for the forecasting period are 0.04 and 12.39, respectively. We have considered Organogenesis Holdings' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Organogenesis Holdings stock data series using in forecasting. Note that when a statistical model is used to represent Organogenesis Holdings stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.2357 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3011 |
| MAPE | Mean absolute percentage error | 0.0627 |
| SAE | Sum of the absolute errors | 18.3662 |
Predictive Modules for Organogenesis Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Organogenesis Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Organogenesis Holdings After-Hype Price Density Analysis
As far as predicting the price of Organogenesis Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Organogenesis Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Organogenesis Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Organogenesis Holdings Estimiated After-Hype Price Volatility
In the context of predicting Organogenesis Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Organogenesis Holdings' historical news coverage. Organogenesis Holdings' after-hype downside and upside margins for the prediction period are 0.20 and 11.17, respectively. We have considered Organogenesis Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Organogenesis Holdings is very risky at this time. Analysis and calculation of next after-hype price of Organogenesis Holdings is based on 3 months time horizon.
Organogenesis Holdings Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Organogenesis Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organogenesis Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Organogenesis Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 7.17 | 0.00 | 0.23 | 0 Events / Month | 2 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.00 | 4.00 | 0.00 |
|
Organogenesis Holdings Hype Timeline
Organogenesis Holdings is now traded for 4.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.23. Organogenesis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.27%. %. The volatility of related hype on Organogenesis Holdings is about 850.53%, with the expected price after the next announcement by competition of 3.77. About 47.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.99. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Organogenesis Holdings recorded a loss per share of 0.08. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Organogenesis Holdings to cross-verify your projections. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Organogenesis Holdings Related Hype Analysis
Having access to credible news sources related to Organogenesis Holdings' direct competition is more important than ever and may enhance your ability to predict Organogenesis Holdings' future price movements. Getting to know how Organogenesis Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Organogenesis Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SNDL | SNDL Inc | (0.03) | 10 per month | 0.00 | (0.10) | 5.06 | (5.88) | 37.98 | |
| MNPR | Monopar Therapeutics | 0.00 | 0 per month | 0.00 | (0.09) | 5.46 | (6.48) | 20.65 | |
| EBS | Emergent Biosolutions | 0.00 | 0 per month | 3.48 | 0.07 | 7.67 | (4.53) | 23.25 | |
| ESPR | Esperion Therapeutics | 0.00 | 0 per month | 4.38 | 0.08 | 7.05 | (7.04) | 24.91 | |
| EOLS | Evolus Inc | 0.00 | 0 per month | 0.00 | (0.14) | 4.43 | (5.29) | 19.71 | |
| SIGA | SIGA Technologies | 0.00 | 0 per month | 0.00 | (0.08) | 3.73 | (2.81) | 23.51 | |
| ANGO | AngioDynamics | (8.55) | 3 per month | 0.00 | (0.07) | 4.34 | (4.55) | 18.26 | |
| BCYC | Bicycle Therapeutics | 0.52 | 14 per month | 0.00 | (0.03) | 5.51 | (5.65) | 13.58 | |
| VREX | Varex Imaging Corp | 0.00 | 0 per month | 3.12 | 0.1 | 3.76 | (2.67) | 17.42 | |
| CMPX | Compass Therapeutics | (0.37) | 9 per month | 3.01 | 0.18 | 7.61 | (5.34) | 16.90 |
Other Forecasting Options for Organogenesis Holdings
For every potential investor in Organogenesis, whether a beginner or expert, Organogenesis Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Organogenesis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Organogenesis. Basic forecasting techniques help filter out the noise by identifying Organogenesis Holdings' price trends.Organogenesis Holdings Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Organogenesis Holdings stock to make a market-neutral strategy. Peer analysis of Organogenesis Holdings could also be used in its relative valuation, which is a method of valuing Organogenesis Holdings by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Organogenesis Holdings Market Strength Events
Market strength indicators help investors to evaluate how Organogenesis Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Organogenesis Holdings shares will generate the highest return on investment. By undertsting and applying Organogenesis Holdings stock market strength indicators, traders can identify Organogenesis Holdings entry and exit signals to maximize returns.
Organogenesis Holdings Risk Indicators
The analysis of Organogenesis Holdings' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Organogenesis Holdings' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting organogenesis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.67 | |||
| Semi Deviation | 3.64 | |||
| Standard Deviation | 7.17 | |||
| Variance | 51.43 | |||
| Downside Variance | 15.5 | |||
| Semi Variance | 13.24 | |||
| Expected Short fall | (5.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Organogenesis Holdings
The number of cover stories for Organogenesis Holdings depends on current market conditions and Organogenesis Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Organogenesis Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Organogenesis Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Organogenesis Holdings Short Properties
Organogenesis Holdings' future price predictability will typically decrease when Organogenesis Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Organogenesis Holdings often depends not only on the future outlook of the potential Organogenesis Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organogenesis Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 131.7 M | |
| Cash And Short Term Investments | 135.6 M |
Check out Historical Fundamental Analysis of Organogenesis Holdings to cross-verify your projections. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Stock sector continue expanding? Could Organogenesis diversify its offerings? Factors like these will boost the valuation of Organogenesis Holdings. Anticipated expansion of Organogenesis directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organogenesis Holdings data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Organogenesis Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organogenesis Holdings' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organogenesis Holdings' market price to deviate significantly from intrinsic value.
It's important to distinguish between Organogenesis Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organogenesis Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organogenesis Holdings' market price signifies the transaction level at which participants voluntarily complete trades.